Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
NCT Number: NCT05587582
This study observes behavioral parenting skills to see whether it could be a novel target for improving pediatric medication adherence. This study may help researchers better understand the challenges parents face when giving their young child with an illness medicine at home and learn about various factors related to medication compliance in young children
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Buffalo, New York, 14263, United States
PRIMARY OBJECTIVES:
I. Use direct observation of medication administration in the home to understand common episode-level barriers and identify the most impactful behavioral parenting skills for intervention.
II. Use daily diary methods to identify contextual barriers to adherence and identify intervention components to help parents anticipate barriers and plan strategies to promote successful adherence.
OUTLINE:
Participants complete a survey over 15-20 minutes at baseline. Family behaviors before, during and after the administration of medication to the child are video-recorded over 40-45 minutes. Participants receive MEMS electronic pill bottle to use for 2 weeks and complete daily survey over 5 minutes for 14 days.
Only the study team can determine whether someone qualifies for participation.
INCLUSION:
Children under age 18 will participate in one aspect of the study, the video recording of medication administration.
Exclusion:
Complete a survey
Time frame: Up to 5 months
Association between ingestion of medication and the absence or presence of each of the Observations of parents and children as they interact with each other during medication administration. Interactions will be coded by trained observers.
Time frame: Up to 5 months
The association between time to ingestion and the DCIPS coded skills will be analyzed
Roswell Park Cancer Institute
Other
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Studies 1 and 2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01503632
Acute Lymphoblastic Leukemia, Hematologic Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT01134575
Acute Lymphoblastic Leukemia, Burkitt Lymphoma
Houston, Texas, United States
View Trial DetailsNCT04975555
Acute Lymphoblastic Leukemia, Blood Protein Disorders
Birmingham, Alabama, United States
View Trial DetailsNCT05969002
Acute Lymphoblastic Leukemia, B Cell
Bethesda, Maryland, United States
View Trial Details